Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements
NCT00365742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2006-08-17
Summary
Randomized trial in a primary prevention population
* all participants have high LDL cholesterol
Group one will take simvastatin 40 mg/day Group Two will make therapeutic lifestyle changes,and take supplements consisting of red yeast rice and fish oil
Conditions
Interventions
- DRUG
-
simvastatin
- DRUG
-
red yeast rice
- DRUG
-
pharmaceutical grade fish oil
- BEHAVIORAL
-
therapeutic lifestyle changes
Sponsors & Collaborators
-
Chestnut Hill Health System
lead OTHER
Principal Investigators
-
David Becker
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Completion
- 2006-06-30
More Related Trials
-
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
NCT00723723 ·Status: COMPLETED
-
Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)
NCT00652847 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
NCT01004705 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
NCT00423579 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
NCT00652327 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
NCT05614765 ·Status: ACTIVE_NOT_RECRUITING
-
Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)
NCT00736463 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
NCT00479713 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
NCT00092157 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)
NCT00651014 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)
NCT00650819 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Choice Decision Aid Implementation First Phase
NCT02375815 ·Status: COMPLETED ·Phase: NA
-
Dose-escalating Safety Study in Subjects on Stable Statin Therapy
NCT00231569 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
NCT00653835 ·Status: COMPLETED ·Phase: PHASE4
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
NCT00143676 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)
NCT00551447 ·Status: COMPLETED ·Phase: PHASE3
-
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
NCT01592240 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
NCT00110435 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
NCT01674712 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
NCT00327691 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
NCT00092664 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
NCT00423488 ·Status: COMPLETED ·Phase: PHASE3
-
Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)
NCT00653523 ·Status: COMPLETED ·Phase: PHASE3